Successful trial for new colorectal cancer treatment

  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 51 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 48%
  • Publisher: 53%

Colon Cancer News

Breast Cancer,Lung Cancer,Cancer

Results from a new phase 1 trial indicate that immunotherapy could be used to treat the most common form of colorectal cancer, also known as bowel cancer.

Consistent responses to immunotherapy have been reported in patients with the most common type of colorectal tumors, known as MSS mCRC, with 61% of patients seeing their tumor shrink or remain stable after receiving treatment.

Co-authored by Professor Justin Stebbing of Anglia Ruskin University , who describes the results as"potentially game changing," the study focused on the most common type of colorectal tumours, known as MSS mCRC, or microsatellite stable metastatic colorectal cancer. Of the patients in the phase 1 trial, 101 took part in a six-month follow-up and of these, 61% of them saw their tumour shrink or remain stable after receiving a combination of botensilimab and balstilimab . The most common side-effects, or treatment-related adverse events, were diarrhea and fatigue.

Joint first author Dr Andrea Bullock, Assistant Professor in Medicine at Beth Israel Deaconess Medical Center, said:"This study sheds light on the potential of the BOT/BAL combination to treat microsatellite stable metastatic colorectal cancer, the most common form of colorectal cancer which has historically not responded to immunotherapy, and we hope our results will offer new hope for those diagnosed.

Source: Healthcare Press (healthcarepress.net)

Breast Cancer Lung Cancer Cancer Pancreatic Cancer Skin Cancer Leukemia Ovarian Cancer

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 452. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

First successful drone delivery trial on Mount Everest completedA Chinese company reached new heights with a drone trial recently.
Source: wsyx6 - 🏆 444. / 53 Read more »

Moderna Announces Good Results From Trial of Combo COVID/Flu VaccineAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday.
Source: MedicineNet - 🏆 575. / 51 Read more »

COVID-flu combination vaccine shows positive results in late-stage trial, Moderna saysThere could be a combined COVID-19 and flu shot in our future
Source: WGAL - 🏆 331. / 59 Read more »

Covid-flu combination vaccine shows positive results in late-stage trial, Moderna saysThere could be a combined Covid-19 and flu shot in our future, although it won’t be ready for this year’s flu season.
Source: cnnbrk - 🏆 393. / 55 Read more »

NJ election results: Andy Kim wins Senate primary amid Menendez trialDemocratic Rep. Andy Kim has won New Jersey’s Senate primary.
Source: fox5ny - 🏆 587. / 51 Read more »

Pfizer's drug for advanced lung cancer shows promising long-term trial resultsThe company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
Source: CNBC - 🏆 12. / 72 Read more »